News

The Manila Times15h
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
FDA designation highlights the potential of PMN310 to deliver a more targeted approach to treating Alzheimer’s Disease ...
Enhancing environmental data sharing: Policy brief provides recommendations
AD4GD, B-Cubed, FAIRiCUBE and USAGE—published a joint policy brief offering recommendations to guide the successful ...